세계의 히알루론산 관절내 보충 요법 시장 : 규모, 점유율, 동향 분석(2025-2031년) - MedCore
Hyaluronic Acid Viscosupplementation Market Size, Share, and Trends Analysis | Global | 2025-2031 | MedCore | Includes: Single Injection Market, Two Injection Market, and 2 more
상품코드:1676627
리서치사:iData Research Inc.
발행일:2025년 01월
페이지 정보:영문 60 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 히알루론산(HA) 관절내 보충 요법 시장 규모는 2024년에 25억 달러에 달했습니다. 이 시장은 2.9%의 CAGR로 확대하며, 2031년에는 30억 달러에 달할 것으로 예측됩니다.
COVID-19 팬데믹으로 인해 선택적 수술이 연기되면서 매출이 일시적으로 감소했습니다. 그러나 2022년까지 시장이 회복되어 안정적인 성장세로 돌아섰습니다.
고령화 인구 증가와 골관절염 환자 증가는 관절내 치환술에 대한 수요를 촉진하고 있습니다.
세계의 히알루론산 관절내 보충 요법 시장에 대해 조사했으며, 시장의 개요와 시장 분석과 예측, 촉진요인과 억제요인, 경쟁 구도 등을 제공하고 있습니다.
목차
개요
경쟁 분석
대상 지역
서론
관절내 보충 요법의 이점
활액
제품 유형
시술 건수
시장 개요
부문별
지역별
시장 분석과 예측
히알루론산 관절내 보충 요법 시장 전체
단회 주사 히알루론산 관절내 보충 요법 시장
2회 주입 히알루론산 관절내 보충 요법 시장
3회 주입 히알루론산 관절내 보충 요법 시장
5회 주사 히알루론산 관절내 보충 요법 시장
촉진요인과 억제요인
경쟁 시장 점유율 분석
KSA
영문 목차
영문목차
The global hyaluronic acid (HA) viscosupplementation market was valued at $2.5 billion in 2024 and is projected to grow at a CAGR of 2.9%, reaching $3 billion by 2031.
This market includes four primary product categories:
Single Injection
Two Injections
Three Injections
Five Injections
Market Insights & Data Coverage
Unit Sales & Average Selling Prices
Market Size & Growth Trends
Procedure Numbers
Market Drivers & Limiters
Market Forecasts Until 2031
Historical Data (2021-2023)
Competitive Landscape, Mergers & Acquisitions
Company Profiles & Product Portfolios
Market Trends
Impact of COVID-19 on Market Growth:
* The COVID-19 pandemic led to a temporary decline in sales due to postponements of elective procedures.
* By 2022, the market rebounded, returning to steady growth.
Growing Prevalence of Osteoarthritis:
* Increased aging population and rising osteoarthritis cases are fueling demand for HA viscosupplementation.
Shift Towards Single-Injection Therapies:
* Convenience and lower patient burden are driving single-injection adoption.
Market Share Insights
Top Competitors in the Global Hyaluronic Acid Viscosupplementation Market (2024):
1 DePuy Synthes
* Market leader with its MONOVISC(R) (single-injection) and ORTHOVISC(R) (three-injection) products.
2 Fidia
* Second-largest market share with its HYMOVIS(R) (two-injection therapy).
3 Sanofi
* Third-largest competitor, offering Synvisc(R) and Synvisc-One(R), benefiting from the growing osteoarthritis market.
Market Segmentation Summary
Hyaluronic Acid Viscosupplementation Market
Single Injection Market
Two Injections Market
Three Injections Market
Five Injections Market
Global Research Scope
Regions Covered:
* North America (U.S., Canada)
* Latin America (Brazil, Mexico, Argentina, Colombia, Chile)
* Western Europe (Germany, France, U.K., Spain, Italy)
* Central & Eastern Europe (Poland, Russia, Turkey, Hungary)
* Middle East (Saudi Arabia, UAE, Israel)
* Asia Pacific (China, Japan, India, South Korea, Australia)
* Africa (South Africa, Egypt, Nigeria, Kenya)
Base Year: 2024
Forecast Period: 2025-2031
Historical Data: 2021-2023
Quantitative Coverage
Market Size, Market Shares
Market Forecasts, Growth Rates
Units Sold, Average Selling Prices
Procedure Numbers
Qualitative Coverage
COVID-19 Impact
Market Growth Trends & Limiters
Competitive Analysis & SWOT for Top Competitors
Mergers & Acquisitions
Company Profiles & Product Portfolios
FDA Recalls, Disruptive Technologies
Disease Overviews
Data Sources:
Primary Interviews with Industry Leaders
Government Physician Data & Regulatory Data
Hospital Private Data
Import & Export Data
iData Research Internal Database
TABLE OF CONTENT
7.1 Executive Summary
7.1.2 Competitive Analysis
7.1.3 Regions Included
7.2 Introduction
7.2.1 Benefits of Viscosupplementation
7.2.2 Synovial Fluid
7.2.3 Product Types
7.2.3.1 Single-Injection Products
7.2.3.2 Two-Injection Cycle Products
7.2.3.3 Three-Injection Cycle Products
7.2.3.4 Three-/Five-Injection Cycle Products
7.3 Procedure Numbers
7.4 Market Overview
7.4.1 By Segment
7.4.2 By Region
7.5 Market Analysis and Forecast
7.5.1 Total Hyaluronic Acid Viscosupplementation Market
